| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytokinetics, Incorporated (CYTK) have been net sellers, shedding 76,163 shares worth roughly $6.0M on balance. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), CYTK's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $30.73M | - | |
| VP | 157.4K | $12.08M | -3,500 | |
| CFO | 100.8K | $7.74M | - | |
| Other | 87.3K | $6.70M | - | |
| VP | 58.6K | $4.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $33.12 | $165,577.00 | -1.4% | +10.1% | +61.3% | |
| Sep 1, 2021 | Cragg David | Chief Hr &Admin Officer | Sell | 7,850 | $32.78 | $257,311.23 | -5.1% | +19.1% | +62.7% | |
| Aug 18, 2021 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $31.14 | $155,711.50 | -1.4% | +29.7% | +67.9% | |
| Aug 12, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 2,000 | $32.60 | $65,200.00 | -1.3% | +21.8% | +55.1% | |
| Aug 5, 2021 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $29.12 | $145,604.00 | -1.4% | +21.3% | +71.4% | |
| Aug 2, 2021 | Cragg David | Chief Hr &Admin Officer | Sell | 2,616 | $29.67 | $77,616.72 | -1.7% | +19.4% | +47.3% | |
| Jul 22, 2021 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $29.82 | $149,121.00 | -1.4% | +18.7% | +28.7% | |
| Jul 19, 2021 | Smith Sandford D48 | Director | Sale+OE | 11,965 | $28.87 | $345,467.50 | -38.2% | +32.5% | +48.1% | |
| Jul 8, 2021 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 2,000 | $19.48 | $38,952.20 | -1.3% | +83.1% | +135.7% | |
| Jul 6, 2021 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $20.13 | $100,668.00 | -1.4% | +86.3% | +126.0% |